ClinicalTrials.gg
Sign In

Lupus Erythematosus, Systemic clinical trials

The registry lists 1,208 studies for Lupus Erythematosus, Systemic across more than 10 countries. 404 are recruiting or about to start. 920 of them are mainly about Lupus Erythematosus, Systemic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its narrower condition Lupus Nephritis too: 1,428 studies, 480 open.

ClinicalTrials.gov finds 1,505 studies for Lupus Erythematosus, Systemic. How that becomes 1,207 here

This page counts the studies the registry files under Lupus Erythematosus, Systemic, and those it files under no condition that list Lupus Erythematosus, Systemicthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,505Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −212Filed under a narrower condition, counted on its own pageLupus Nephritis 212
  3. −10List Lupus Erythematosus, Systemic as a condition, but the registry did not file them under itMost often written as “Juvenile Systemic Lupus Erythematosus” (3), “Neuropsychiatric Systemic Lupus Erythematosus” (1), and “Bullous Systemic Lupus Erythematosus” (1). The registry filed them under other conditions only, most often Dermatomyositis (2) and Arthritis, Juvenile (2).
  4. −76Match it another way61 name it in the title and 15 by a synonym or other text the search reads.
  5. 1,207The count on this page22 of them list Lupus Erythematosus, Systemic in their own words; the registry filed them under no condition.

Get an email when these change. Save the Lupus Erythematosus, Systemic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
476
Recruiting
283
Status unknown
119
Not yet recruiting
102
Terminated
87
Active, not recruiting
71

Phase

Phase 1
288
Phase 2
272
Phase 3
125
Phase 4
58
Early Phase 1
46

Where

United States
477
China
265
France
168
Spain
144
Germany
124
Poland
112

Who runs them

AstraZeneca (39) · Assiut University (37) · GlaxoSmithKline (30) · Assistance Publique - Hôpitaux de Paris (21) · Amgen (20) · Sohag University (17) · Bristol-Myers Squibb (15) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (15)

What is being tested here

Drugs under test in Lupus Erythematosus, Systemic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Anifrolumab8516
Telitacicept6413
YTS109606
Belimumab41136
Mycophenolic Acid4314
Cyclophosphamide4111
Interleukin-23310
Enpatoran336
Fludarabine306
Anti-CD19/Anti-CD3/Anti-CD28 Trispecific Antibody CC312303

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 6 open · Antimetabolites 4 open · Alkylating agents 4 open · JAK inhibitors 3 open · Corticosteroids 2 open

Coming up

42phase 3 studies under way
128studies finish main data collection within a year9 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 283 Lupus Erythematosus, Systemic studies recruiting now, 92 (33%) set no upper age limit and 161 (57%) stop at 75 or younger. 54 (19%) take children under 18. 14 (5%) are for women only and 0 (0%) for men only; 33 (12%) take healthy volunteers.

Recruiting studies that take each age, of 283
AgeWomenMen
1037 (13%)34 (12%)
18270 (95%)257 (91%)
30266 (94%)252 (89%)
40265 (94%)251 (89%)
50265 (94%)253 (89%)
65243 (86%)233 (82%)
75149 (53%)141 (50%)
85112 (40%)104 (37%)

Across all 1,208 studies, recruiting or not: 53% stop at 75 or younger and 31% at 65; 18% take children; 9% are for women only and 1% for men only; 15% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Lupus Erythematosus, Systemic studies take

Of 147 phase 1 interventional studies under Lupus Erythematosus, Systemic, half reached primary completion within 28 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 128 mo16–36 · 147 studies28 mo13–35 · 108 studies—
Phase 1/242 mo21–60 · 37 studies——
Phase 236 mo27–56 · 95 studies32 mo25–48 · 67 studies—
Phase 351 mo38–84 · 53 studies——
Phase 433 mo30–42 · 33 studies——
Interventional, no phase23 mo10–38 · 129 studies—23 mo10–38 · 122 studies
Observational64 mo34–126 · 112 studies—59 mo30–212 · 90 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting4

Results posted1

Stopped3

Newly registered9

Show 4 more

Studies

Recruiting first, then most recently updated. Showing 50 of 1,208. Browse all 1,208 → or search them.